These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 2685984

  • 1. Zidovudine treatment of AIDS and ARC in Denmark 1987.
    Teglbjaerg LL, Mathiesen LR, Søeberg B, Nielsen L, Thorsen B, Buhl M, Pedersen C, Bonnevie O, Nielsen C, Vestergaard BF.
    Scand J Infect Dis; 1989; 21(4):367-73. PubMed ID: 2685984
    [Abstract] [Full Text] [Related]

  • 2. Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: St Stephen's Hospital experience.
    Stambuk D, Hawkins D, Gazzard BG.
    J Infect; 1989 Jan; 18 Suppl 1():41-51. PubMed ID: 2492585
    [Abstract] [Full Text] [Related]

  • 3. The efficacy and toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex (ARC): an open uncontrolled treatment study.
    Stambuk D, Youle M, Hawkins D, Farthing C, Shanson D, Farmer R, Lawrence A, Gazzard B.
    Q J Med; 1989 Feb; 70(262):161-74. PubMed ID: 2512592
    [Abstract] [Full Text] [Related]

  • 4. The effect of treatment with zidovudine with or without acyclovir on HIV p24 antigenaemia in patients with AIDS or AIDS-related complex.
    Pedersen C, Cooper DA, Brun-Vézinet F, Doherty R, Skinhøj P, Pérol Y, Lüthy R, Leibowitch J, Habermehl KO, Varnier OE.
    AIDS; 1992 Aug; 6(8):821-5. PubMed ID: 1418778
    [Abstract] [Full Text] [Related]

  • 5. The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: a double-blind randomized trial. European-Australian Collaborative Group.
    Cooper DA, Pehrson PO, Pedersen C, Moroni M, Oksenhendler E, Rozenbaum W, Clumeck N, Faber V, Stille W, Hirschel B.
    AIDS; 1993 Feb; 7(2):197-207. PubMed ID: 8096703
    [Abstract] [Full Text] [Related]

  • 6. Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial.
    Chaisson RE, Leuther MD, Allain JP, Nusinoff-Lehrman S, Boone GS, Feigal D, Volberding P.
    Arch Intern Med; 1988 Oct; 148(10):2151-3. PubMed ID: 3263098
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of zidovudine treatment in homosexual men with AIDS-related complex: factors influencing development of AIDS, survival and drug intolerance. Australian Zidovudine Study Group.
    Swanson CE, Tindall B, Cooper DA.
    AIDS; 1994 May; 8(5):625-34. PubMed ID: 8060543
    [Abstract] [Full Text] [Related]

  • 8. Effect of azidothymidine (AZT) on P24 antigen levels in patients with AIDS-related complex and AIDS.
    Reddy MM, McKinley G, Englard A, Grieco MH.
    J Clin Lab Anal; 1989 May; 3(4):199-201. PubMed ID: 2503599
    [Abstract] [Full Text] [Related]

  • 9. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
    Chaisson RE, Moore RD, Richman DD, Keruly J, Creagh T.
    Am Rev Respir Dis; 1992 Aug; 146(2):285-9. PubMed ID: 1362634
    [Abstract] [Full Text] [Related]

  • 10. A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
    Fischl MA, Parker CB, Pettinelli C, Wulfsohn M, Hirsch MS, Collier AC, Antoniskis D, Ho M, Richman DD, Fuchs E.
    N Engl J Med; 1990 Oct 11; 323(15):1009-14. PubMed ID: 1977079
    [Abstract] [Full Text] [Related]

  • 11. Zidovudine--the first year of experience.
    Williams I, Gabriel G, Cohen H, Williams P, Tedder RS, Machin S, Weller IV.
    J Infect; 1989 Jan 11; 18 Suppl 1():23-31. PubMed ID: 2915140
    [No Abstract] [Full Text] [Related]

  • 12. Response of serum p24 antigen and antibody to p24 antigen in patients with AIDS and AIDS-related complex treated with zidovudine.
    Williams IG, Gabriel G, Kelly G, Loveday C, Tedder RS, Weller IV.
    AIDS; 1990 Sep 11; 4(9):909-12. PubMed ID: 2123627
    [Abstract] [Full Text] [Related]

  • 13. [HIV-correlated antigens and antibodies in patients treated with zidovudine].
    Garavelli PL, Dallavalle FM.
    Minerva Med; 1990 Sep 11; 81(7-8 Suppl):93-4. PubMed ID: 2216047
    [Abstract] [Full Text] [Related]

  • 14. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
    Fischl MA, Richman DD, Hansen N, Collier AC, Carey JT, Para MF, Hardy WD, Dolin R, Powderly WG, Allan JD.
    Ann Intern Med; 1990 May 15; 112(10):727-37. PubMed ID: 1970466
    [Abstract] [Full Text] [Related]

  • 15. Current and future trials with zidovudine.
    Yeo JM.
    J Infect; 1989 Jan 15; 18 Suppl 1():93-6. PubMed ID: 2644366
    [Abstract] [Full Text] [Related]

  • 16. Clinical experience with zidovudine for patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex.
    Pinching AJ, Helbert M, Peddle B, Robinson D, Janes K, Gor D, Jeffries DJ, Stoneham C, Mitchell D, Kocsis AE.
    J Infect; 1989 Jan 15; 18 Suppl 1():33-40. PubMed ID: 2521663
    [Abstract] [Full Text] [Related]

  • 17. Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and enhanced lymphocyte proliferation.
    Crumpacker C, Heagy W, Bubley G, Monroe JE, Finberg R, Hussey S, Schnipper L, Lucey D, Lee TH, McLane MF.
    Ann Intern Med; 1987 Nov 15; 107(5):664-74. PubMed ID: 3662279
    [Abstract] [Full Text] [Related]

  • 18. T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS.
    Levacher M, Tallet S, Dazza MC, Dournon E, Rouveix B, Pocidalo JJ.
    Clin Exp Immunol; 1990 Aug 15; 81(2):177-82. PubMed ID: 1696859
    [Abstract] [Full Text] [Related]

  • 19. Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex.
    Dournon E, Matheron S, Rozenbaum W, Gharakhanian S, Michon C, Girard PM, Perronne C, Salmon D, De Truchis P, Leport C.
    Lancet; 1988 Dec 03; 2(8623):1297-302. PubMed ID: 2904016
    [Abstract] [Full Text] [Related]

  • 20. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
    Jacobson MA, Bacchetti P, Kolokathis A, Chaisson RE, Szabo S, Polsky B, Valainis GT, Mildvan D, Abrams D, Wilber J.
    BMJ; 1991 Jan 12; 302(6768):73-8. PubMed ID: 1671651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.